77 results
8-K
ALGS
Aligos Therapeutics Inc
31 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
its noncompliance with Nasdaq Listing Rule 5605 (“Rule 5605”), which requires, among other things, that the Audit Committee (the “Audit Committee … resigned as a member of the Board and all committees of the Board, including the Audit Committee, effective as of May 21, 2024, resulting
8-K
ALGS
Aligos Therapeutics Inc
22 May 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:02pm
”), resigned from the Board.
Following Mr. Nielsen’s departure, a vacancy was created on the Company’s Audit Committee, resulting in there being two … members of the Audit Committee (the “Vacancy”). Nasdaq Stock Market LLC Listing Rule 5605(c)(2)(A) requires that the Company have an Audit Committee
DEFA14A
knm1qcl8h
29 Apr 24
Additional proxy soliciting materials
4:04pm
PRE 14A
nfpt3ixj3e069t9qr ed
16 Apr 24
Preliminary proxy
5:27pm
424B3
wt3 lolxsl6tkqitr3c
28 Nov 23
Prospectus supplement
4:01pm
8-K
EX-10.1
a6vdk4
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm